Saroja Pharma Industries India (NSE:SAROJA) EV-to-EBITDA : 10.81 (As of Dec. 13, 2024)

Saroja Pharma Industries India EV-to-EBITDA Chart

Competitive Comparison of Saroja Pharma Industries India's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Saroja Pharma Industries India's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Saroja Pharma Industries India's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Saroja Pharma Industries India's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Saroja Pharma Industries India's EV-to-EBITDA falls into.

Saroja Pharma Industries India EV-to-EBITDA Calculation

Saroja Pharma Industries India's EV-to-EBITDA for today is calculated as:

Saroja Pharma Industries India's current Enterprise Value is ₹279.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Saroja Pharma Industries India's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹25.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saroja Pharma Industries India  (NSE:SAROJA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Saroja Pharma Industries India's PE Ratio (TTM) for today is calculated as:

Saroja Pharma Industries India's share price for today is ₹55.95.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Saroja Pharma Industries India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹2.490.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Saroja Pharma Industries India EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Saroja Pharma Industries India's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Saroja Pharma Industries India Business Description